B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

IFNB1

MOLECULAR TARGET

interferon beta 1

UniProt: P01574NCBI Gene: 345647 compounds

IFNB1 (interferon beta 1) is targeted by 47 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting IFNB1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Camptothecin2.4811
2Ouabain2.4010
3withaferin2.309
4celastrol2.087
5Disulfiram2.087
6Idarubicin2.087
7Bortezomib1.956
8cycloheximide1.956
9Emetine1.956
10Proscillaridin1.956
11Crizotinib1.795
12Dactinomycin1.795
13Daunorubicin1.795
14Epirubicin1.795
15Homoharringtonine Semisynthetic derivative of harringtonine that acts as1.795
16trichostatic acid [Supplementary Concept] related to trichostatin1.795
17Tripterygium1.795
18Azacitidine1.614
19Azacitidine1.614
20Calcimycin1.614
213-(1-(3-hydroxy-4-methoxyphenyl)methylidene)-6-methylchroman-4-one [Supplementary Concept]1.614
22kenpaullone1.614
23cbd1.393
24cannabidiol1.393
25Deslanoside Deacetyllanatoside C.1.393
26Digitoxin1.393
27Digoxin1.393
28Feprazone1.393
29Leflunomide1.393
30triolimus [Supplementary Concept]1.393
31Thapsigargin1.393
32Genistein1.102
33Sertraline1.102
34Nitrendipine1.102
35Phenylbutazone1.102
36Luteolin 5,7,3',4'-tetrahydroxy-flavone,0.691
37Methylene Blue0.691
38Warfarin0.691
39Afatinib0.691
40C75-coenzyme0.691
41casin0.691
42Fluspirilene0.691
43Isopentenyladenosine N(6)-[delta(3)-isopentenyl]adenosine. Isopentenyl derivative of adenosine which is0.691
44Sorafenib0.691
45sp6001250.691
46Trabectedin0.691
47tyrphostin ag 14780.691

About IFNB1 as a Drug Target

IFNB1 (interferon beta 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 47 compounds with documented IFNB1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

IFNB1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.